Polymorphisms of genes related to endothelial cells are associated with primary biliary cirrhosis patients of Cretan origin

Human Immunology

Volumn 73, Issue 8, 2012, Pages 829-835

  Mantaka, Ai ^a   Goulielmos, G N ^a   Koulentaki, M ^b   Tsagournis, O ^b   Voumvouraki, A ^b   Kouroumalis, E A ^b  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN; GENOMIC DNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; ENDOTHELIUM; FEMALE; GENE REPLICATION; GENETIC ASSOCIATION; GREECE; HUMAN; HUMAN CELL; INTRON; LIVER; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

AGED; AGED, 80 AND OVER; ALLELES; CTLA-4 ANTIGEN; ENDOTHELIAL CELLS; ENDOTHELIN-1; EXONS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GREECE; HUMANS; INTRONS; LIVER; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84864033381     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.05.003     Document Type: Article

References (52)

1. James O.F., Bhopal R., Howel D., Gray J., Burt A.D., Metcalf J.V. Primary biliary cirrhosis once rare, now common in the United Kingdom?. Hepatology 1999, 30:390-394.
2. Sherlock S., Dooley J. Primary biliary cirrhosis. Diseases of the liver and biliary system 1993, Blackwell, Oxford.
3. Bach N., Schaffner F. Familial primary biliary cirrhosis. J Hepatol 1994, 20:698-701.
4. Yanagisawa M., Takagi H., Takahashi H., Uehara M., Otsuka T., Yuasa K., et al. Familial clustering and genetic background of primary biliary cirrhosis in Japan. Dig Dis Sci 2010, 55:2651-2658.
5. Selmi C., Mayo M.J., Bach N., Ishibashi H., Invernizzi P., Gish R.G., et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 2004, 127:485-492.
6. Lozano A., Vildósola H., Takano J., Vargas G., Uribe R., Moreno C. Clinical and immunological profile in 22 patients with primary biliary cirrhosis. Rev Gastroenterol Peru 2000, 20:14-24.
7. Watt F.E., James O.F., Jones D.E. Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. QJM 2004, 97(7):397-406.
8. Poupon R., Ping C., Chretien Y., Corpechot C., Chazouilleres O., Simon T., et al. Genetic factors of susceptibility and of severity in primary biliary cirrhosis. J Hepatol 2008, 49:1038-1045.
9. Hirschfield G.M., Liu X., Xu C., Lu Y., Xie G., Gu X., et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009, 360:2544-2555.
10. Mells G.F., Floyd J.A., Morley K.I., Cordell H.J., Franklin C.S., Shin S.Y., et al. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet 2011, 43(4):329-432.
11. Tiret L. Gene-environment interaction: a central concept in multifactorial diseases. Proc Nutr Soc 2002, 61:457-463.
12. Jones D.E., Donaldson P.T. Genetic factors in the pathogenesis of primary biliary cirrhosis. Clin Liver Dis 2003, 7:841-864.
13. Juran B.D., Lazaridis K.N. Update on the genetics and genomics of primary biliary cirrhosis. J Autoimmun 2010, 35:181-187.
14. Tanaka A., Nezu S., Uegaki S., Kikuchi K., Shibuya A., Miyakawa H., et al. Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations. J Hepatol 2009, 50:1202-1209.
15. Tanaka A., Ohira H., Kikuchi K., Nezu S., Shibuya A., Bianchi I., et al. Genetic association of Fc receptor-like 3 polymorphisms with susceptibility to primary biliary cirrhosis: ethnic comparative study in Japanese and Italian patients. Tissue Antigens 2011 Mar, 77(3):239-243.
16. Dimoulios P., Kolios G., Notas G., Matrella E., Xidakis K., Koulentaki M., et al. Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis. Aliment Pharmacol Ther 2005, 21:227-234.
17. Kouroumalis E., Notas G. Pathogenesis of primary biliary cirrhosis: a unifying model. World J Gastroenterol 2006, 12:2320-2327.
18. Clemens M.G. Nitric oxide in liver injury. Hepatology 1999, 30:1-5.
19. Li J., Billiar T.R. Nitric oxide. IV. Determinants of nitric oxide protection and toxicity in liver. Am J Physiol 1999, 276:G1069-G1073.
20. Battista S., Bar F., Mengozzi G., Pollet C., Torchio M., Cavalli G., et al. Evidence of an increased nitric oxide production in primary biliary cirrhosis. Am J Gastroenterol 2001, 96:869-875.
21. Zhang M., Luo B., Chen S.J., Abrams G.A., Fallon M.B. Endothelin-1 stimulation of endothelial nitric oxide synthase in the pathogenesis of hepatopulmonary syndrome. Am J Physiol 1999, 277:G944-G952.
22. Selmi C., Zuin M., Biondi M.L., Invernizzi P., Battezzati P.M., Bernini M., et al. Genetic variants of endothelial nitric oxide synthase in patients with primary biliary cirrhosis: association with disease severity. J Gastroenterol Hepatol 2003, 18:1150-1155.
23. Invernizzi P., Gershwin M.E. The genetic basis of primary biliary cirrhosis: premises, not promises. Gastroenterology 2008, 135:1044-1047.
24. Mattner J. Genetic susceptibility to autoimmune liver disease. World J Hepatol 2011, 3(1):1-7.
25. Juran B.D., Atkinson E.J., Schlicht E.M., Fridley B.L., Lazaridis K.N. Primary biliary cirrhosis is associated with a genetic variant in the 3- flanking region of the CTLA4 gene. Gastroenterology 2008, 135:1200-1206.
26. Walker E.J., Hirschfield G.M., Xu C., Lu Y., Liu X., Coltescu C., et al. CTLA4/ICOS gene variants and haplotypes are associated with rheumatoid arthritis and primary biliary cirrhosis in the Canadian population. Arthritis Rheum 2009, 60:931-937.
27. Juran B.D., Atkinson E.J., Larson J.J., Schlicht E.M., Liu X., Heathcote E.J., et al. Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T-lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: evidence for a gene-gene interaction. Hepatology 2010, 52(1):223-229.
28. Juran B.D., Atkinson E.J., Schlicht E.M., Fridley B.L., Petersen G.M., Lazaridis K.N. Interacting genes of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis. Hepatology 2008, 47:563-570.
29. Ludwig J., Dickson E.R., McDonald G.S. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 1978, 379:103-112.
30. Dickson E.R., Grambsch P.M., Fleming T.R., Fisher L.D., Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989, 10:1-7.
31. Miyahara K., Kawamoto T., Sase K., Yui Y., Toda K., Yang L.X., et al. Cloning and structural characterization of the human endothelial nitric oxide synthase gene. Eur J Biochem 1994, 223:719-726.
32. Srivastava K., Biswas U.K., Narang R., Varghese J.J., Das N. Prevalence of eNOS Glu298Asp polymorphism in healthy volunteers from a region of Northern India. Community Genet 2005, 8:180-183.
33. Agarwal K., Jones D.E., Daly A.K., James O.F., Vaidya B., Pearce S., et al. CTLA-4 gene polymorphisms confers susceptibility to primary biliary cirrhosis. J Hepatol 2000, 32:538-541.
34. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003, 423:506-511.
35. Moser K.L., Kelly J.A., Lessard C.J., Harley J.B. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun 2009, 10:373-379.
36. Liu X., Invernizzi P., Lu Y., Kosoy R., Lu Y., Bianchi I., et al. Genomewide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet 2010, 42:658-660.
37. Nakamura M., Yasunami M., Kondo H., Horie H., Aiba Y., Komori A., et al. PBC Study Group in NHOSLJ Analysis of HLA-DRB1 polymorphisms in Japanese patients with primary biliary cirrhosis (PBC): the HLA-RB1polymorphism determines the relative risk of antinuclear antibodies for disease progression in PBC. Hepatol Res 2010, 40:494-504.
38. Ohishi Y., Nakamura M., Iio N., Higa S., Inayoshi M., Aiba Y., et al. Single-nucleotide polymorphism analysis of the multidrug resistance protein 3 gene for the detection of clinical progression in Japanese patients with primary biliary cirrhosis. Hepatology 2008, 48:853-862.
39. Joshita S., Umemura T., Yoshizawa K., Katsuyama Y., Tanaka E. Study group. A2BP1 as a novel susceptible gene for primary biliary cirrhosis in Japanese patients. Hum Immunol 2010, 71:520-524.
40. Kim H.J., Choi C.P., Uhm Y.K., Kim Y.I., Lee J.W., Yoon S.H., et al. The association between endothelin-1 gene polymorphisms and susceptibility to vitiligo in a Korean population. Exp Dermatol 2007, 16:561-566.
41. Vasků V., Vasků A., Tschöplová S., Izakovicová Hollá L., Semrádová V., Vácha J. Genotype association of C(-735)T polymorphism in matrix metalloproteinase 2 gene with G(8002)A endothelin 1 gene with plaque psoriasis. Dermatology 2002, 204:262-265.
42. Fonseca C., Renzoni E., Sestini P., Pantelidis P., Lagan A., Bunn C., et al. Endothelin axis polymorphisms in patients with scleroderma. Arthritis Rheum 2006, 54:3034-3042.
43. Smyth A.E., Hughes A.E., Bruce I.N., Bell A.L. A case-control study of candidate vasoactive mediator genes in primary Raynaud's phenomenon. Rheumatology 1999, 38:1094-1098.
44. Roskams T., Van de Casteele M., Nevens F., Desmet V., Fevery J. Enhanced co-expression of eNOS and iNOS in dilated sinusoids in advanced primary biliary cirrhosis, suggests a role for these NOS isoforms in intrahepatic portohepatic blood shunting. Hepatology 2000, 32:408A.
45. Mackay I.R. The" Autoimmune diseases" 40th anniversary. Autoimmun Rev 2002, 1:5-11.
46. Donaldson P., Veeramani S., Baragiotta A., Floreani A., Venturi C., Pearce S., et al. Cytotoxic T-lymphocyte-associated antigen-4 single nucleotide polymorphisms and haplotypes in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2007, 5:755-760.
47. Bittencourt P.L., Palacios S.A., Farias A.Q., Abrantes-Lemos C.P., Cancado E.L., Carrilho F.J., et al. Analysis of major histocompatibility complex and CTLA-4 alleles in Brazilian patients with primary biliary cirrhosis. J Gastroenterol Hepatol 2003, 18:1061-1066.
48. Joshita S., Umemura T., Yoshizawa K., Katsuyama Y., Tanaka E., Nakamura M., et al. The Shinshu PBC study group. association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients. J Hepatol 2010, 53:537-554.
49. Oertelt S., Kenny T.P., Selmi C., Invernizzi P., Podda M., Gershwin M.E. SNP analysis of genes implicated in T cell proliferation in primary biliary cirrhosis. Clin Dev Immunol 2005, 12:259-263.
50. Aiba Y., Nakamura M., Joshita S., Inamine T., Komori A., Yoshizawa K., et al. Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients. J Gastroenterol 2011, 46:1203-1212.
51. Peltonen L., Jalanko A., Varilo T. Molecular genetics of the Finnish disease heritage. Hum Mol Genet 1999, 8:1913-1923.
52. Heutink P., Oostra B.A. Gene finding in genetically isolated populations. Hum Mol Genet 2002, 11:2507-2515.